Fairview Pharmacy Services, part of an academic health system, comprises 35+ outpatient pharmacies in Minneapolis, Minnesota. In 2013, the nonprofit organization opened a satellite location at the University of Minnesota Psychiatry Clinic. The original goals of the service were to improve patient satisfaction and medication adherence through comprehensive pharmaceutical care and clinic provider support. A clozapine monitoring program was envisioned and developed by the pharmacists and now provides optimal medication monitoring, dispensing, and coordination for approximately 100 patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513055 | PMC |
| http://dx.doi.org/10.9740/mhc.2019.05.138 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force.
Eur Psychiatry
January 2025
Mental Health Services Noord-Holland-Noord, Alkmaar, the Netherlands; Dutch Clozapine Collaboration Group, Alkmaar, the Netherlands.
Pharmacogenomic variation and sedation outcomes during early intensive care unit admission: A pragmatic study.
Clin Transl Sci
December 2024
Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Article Synopsis
- Unpredictable reactions to sedatives and analgesics in critically ill patients on mechanical ventilation may stem from genetic differences.
- The study aimed to explore the relationship between pharmacogenomic variations and sedation outcomes, while also assessing ICU patients' views on pharmacogenomic testing.
- The researchers found that while participants showed a median of 2 altered pharmacogenomic phenotypes, there were no significant links between these genetic variations and sedation effectiveness; however, ICU patients generally had positive attitudes towards pharmacogenomic testing.
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation.
Schizophr Bull
December 2024
School of Medicine, University College Dublin, Dublin, D04 V1W8, Ireland.
Background: Overweight and obesity are highly prevalent in people with severe mental illness (SMI). Antipsychotic-induced weight gain (AIWG) is one of the most commonly reported and distressing side effects of treatment and people living with SMI place a high value on the avoidance of this side effect. Metformin is the most effective pharmacological intervention studied for the prevention of AIWG yet clear guidelines are lacking and evidence has not translated into practice.
View Article and Find Full Text PDFCharacteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis.
Rheumatol Ther
November 2024
Horizon Therapeutics (Now Amgen Inc.), 1 Horizon Way, Deerfield, IL, 60015, USA.
Article Synopsis
- Gout is a painful form of arthritis that can lead to more severe health issues when not properly treated; Pegloticase is a drug used to treat patients who do not respond to standard gout treatments.
- A study analyzed data from over 400 patients with chronic uncontrolled gout and found that their condition worsened significantly in the two years leading up to starting pegloticase therapy, with increases in gout-related symptoms and healthcare usage.
- The findings suggest that identifying and treating patients sooner could help reduce the complications and healthcare needs associated with uncontrolled gout.
Impact of tele-antimicrobial stewardship at two small community hospitals in partnership with an academic medical center: two years of experience.
Antimicrob Steward Healthc Epidemiol
September 2024
M Health Fairview University of Minnesota Medical Center, Minneapolis, MN, USA.
Objective: To analyze the impact of a fully remote tele-antimicrobial stewardship program (TASP) at two small community hospitals in partnership with an academic medical center.
Design: Retrospective survey from August 1, 2020, to July 31, 2022.
Setting: A TASP, co-led by an infectious diseases (ID) physician and ID pharmacist, was implemented at M Health Fairview (MHF) Northland, a 21-bed hospital, and at MHF Lakes, a 49-bed hospital.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!